Literature DB >> 8421076

Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIM 1.

K Zeki1, Y Nakano, N Inokuchi, K Watanabe, I Morimoto, U Yamashita, S Eto.   

Abstract

We reported first in this study that human thyroid cell line NIM 1 established from a patient with papillary adenocarcinoma of the thyroid associated with hypercalcemia and peripheral neutrocytosis produced interleukin (IL)-1 alpha and IL-1 beta in the culture supernatant and cell lysate as detected by murine thymocyte proliferative response and enzyme-linked immunosorbent assay. Production of IL-1 alpha and IL-1 beta was further confirmed by the demonstration of IL-1 alpha and IL-1 beta messenger ribonucleic acid expression with Northern blot hybridization analysis. The in vitro growth of NIM 1 cells was inhibited by the addition of anti-IL-1 alpha and IL-1 beta antibody. The growth of NIM 1 cells was further enhanced by the addition of recombinant human IL-1 alpha and IL-1 beta, whereas this enhancement was also inhibited by the addition of anti-IL-1 antibody. IL-1 receptors were expressed on NIM 1 cells. These results suggest that IL-1 plays a regulatory role in the growth of NIM 1 cells by an autocrine mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8421076     DOI: 10.1210/jcem.76.1.8421076

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Association between a functional insertion/deletion polymorphism in IL1A gene and risk of papillary thyroid carcinoma.

Authors:  Linbo Gao; Xinxin Zhu; Zhihui Li; Lijuan Li; Tao Wang; Huaizhong Hu; Wanli Guo; Peng Chen; Jingqiang Zhu; Lin Zhang
Journal:  Tumour Biol       Date:  2014-01-23

2.  IL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysis.

Authors:  Daye Cheng; Yiwen Hao; Wenling Zhou
Journal:  Onco Targets Ther       Date:  2014-11-10       Impact factor: 4.147

3.  Interleukin 1 modulates growth of human renal carcinoma cells in vitro.

Authors:  I Koch; H Depenbrock; S Danhauser-Riedl; J W Rastetter; A R Hanauske
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

4.  UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.

Authors:  P Pallante; M T Berlingieri; G Troncone; M Kruhoffer; T F Orntoft; G Viglietto; A Caleo; I Migliaccio; M Decaussin-Petrucci; M Santoro; L Palombini; A Fusco
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

5.  Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.

Authors:  Elisabeth Oelmann; Harald Stein; Wolfgang E Berdel; Hermann Herbst
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

6.  Stimulatory effect of interleukin-1 alpha on proliferation through a Ca2+/calmodulin-dependent pathway of a human thyroid carcinoma cell line, NIM 1.

Authors:  N Inokuchi; K Zeki; I Morimoto; Y Nakano; T Fujihira; U Yamashita; N Yanagihara; F Izumi; S Eto
Journal:  Jpn J Cancer Res       Date:  1995-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.